- Potential benefitRaises national awareness of overdose risks and prevention, potentially increasing public attention and advocacy.
- Potential benefitReduces stigma by promoting recognition of substance use disorder as a chronic health condition.
- Potential benefitEncourages bipartisan legislative action, potentially accelerating laws expanding treatment and harm reduction services.
Supporting the goals of Overdose Awareness Day and strengthening efforts to combat the opioid crisis in the United States.
Referred to the House Committee on Energy and Commerce.
This resolution is a statement by the House of Representatives recognizing Overdose Awareness Day and declaring support for stronger efforts against the opioid crisis. It expresses the House's views, encourages passing bipartisan policies, and affirms a commitment to work with states, communities, and organizations on prevention, treatment, harm reduction, and recovery. It does not create binding law, require agencies to act, or allocate money. Only the House can adopt this kind of resolution, and it does not become law or need the President's signature.
This House resolution recognizes Overdose Awareness Day and cites CDC provisional data on overdose deaths.
It affirms that substance use disorder is a chronic health issue, notes racial disparities, and commits the House to advancing bipartisan policies and collaborating with states and stakeholders to promote prevention, treatment, harm reduction, and recovery from opioid use disorder.
Text is a nonbinding House resolution expressing support, not a statutory bill subject to enactment.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly defines the problem and expresses congressional support and general commitments, but it provides minimal operational detail, implementation pathways, fiscal acknowledgment, or accountability mechanisms.
Support for harm reduction versus preference for treatment/enforcement
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenNonbinding symbolic resolution does not authorize funding or create enforceable programs.
- Potential burdenMay be criticized as insufficient without concrete legislative, funding, or regulatory actions.
- Potential burdenCould reignite disputes over harm reduction policies, complicating bipartisan agreement on practical measures.
Why the argument around this bill splits.
Support for harm reduction versus preference for treatment/enforcement
Likely strongly supportive of the resolution’s focus on destigmatization, harm reduction, and addressing racial disparities.
Views it as a useful symbolic step but will press for concrete policy, funding, and equity-focused measures.
Generally supportive of recognizing the crisis and promoting bipartisan action.
Sees the resolution as constructive but wants measurable goals, cost estimates, and respect for state roles before backing major initiatives.
May accept recognizing overdose awareness and reducing stigma, but is wary of explicit endorsement of harm reduction.
Prefers treatment, enforcement, family- and faith-based recovery solutions and minimal new federal mandates or spending.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Text is a nonbinding House resolution expressing support, not a statutory bill subject to enactment.
- Whether the House will schedule consideration promptly
- Whether 'harm reduction' phrasing provokes targeted objections
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Support for harm reduction versus preference for treatment/enforcement
Text is a nonbinding House resolution expressing support, not a statutory bill subject to enactment.
Relative to its intended legislative type, this bill is a straightforward commemorative resolution that clearly defines the problem and expresses congressional support and general commitments, but it provides minimal op…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.